v3.25.2
Share Capital (Tables)
 6 Months Ended
Jun. 30, 2025
Share Capital [Abstract]  
Schedule of Shares Issued Granted Options

In the six months ended June 30, 2024, the Company granted options as follows:

 

   Six months ended June 30, 2024
   Number of
options granted		   Exercise
price
range		   Vesting
period		   Expiration
Employees   41,500   $5.26-5.76    4 years   10 years
Consultant   5,000   $5.26    4 years   10 years
Schedule of Fair Value of Options Granted

The fair value of options granted on the date of grant was computed using the Black-Scholes model. The underlying data used for computing the fair value of the options are as follows:

 

   Six months ended
June 30		 
   2024 
Value of ordinary share  $5.13-5.46 
Dividend yield   0%
Expected volatility   70.91-70.97%
Risk-free interest rate   4.35-4.46%
Expected term   6.11 years 
Schedule of Options Granted to Employees and Directors

The following table summarizes the activity in options granted to employees and directors for the six months period ended June 30, 2025:

 

   Number of
options		   Weighted
average
exercise
price		   Weighted
average
remaining
contractual
term
(in years)		   Aggregate
intrinsic
value		 
Options outstanding at the beginning of the period   1,727,755   $5.75    4.99   $
             -
 
Expired   (50,704)   5.80    -    
-
 
Forfeited   (30,220)   6.34    -    
-
 
Options outstanding at the end of the period   1,646,831   $5.74    4.96   $
-
 
Options exercisable at the end of the period   1,430,074   $5.68    4.61   $
-
 
   Number of
options		   Weighted
average
exercise
price		   Weighted
average
remaining
contractual
term
(in years)		   Aggregate
intrinsic
value		 
Options outstanding at the beginning of the period   36,666   $8.35    6.78   $
                -
 
Expired   (11,666)   17.04    -    
-
 
Options outstanding at the end of the period   25,000   $4.46    9.28   $
-
 
Options exercisable at the end of the period   1,250   $5.26    8.76   $
-
 
Schedule of Granted Restricted Share Units

In the six months ended June 30, 2024, the Company granted restricted share units, or RSUs, as follows:

 

   Six months ended
June 30, 2024		 
   Number of
RSUs granted		   Weighted
Average
Grant
Date Fair
Value		 
Employees   261,000   $5.13 
Schedule of Activity in RSU Granted to Employees and Directors

The following table summarizes the activity in RSUs granted to employees under the 2024 Plan for the six months period ended June 30, 2025:

 

   Number of
options		   Weighted
Average
Grant Date
Fair
Value		 
Unvested at the beginning of the period   441,000   $4.99 
Exercised into ordinary shares   (61,500)   5.13 
Forfeited   (15,000)   5.13 
Unvested at the end of the period   364,500   $4.95 
Schedule of Share-Based Compensation The following table illustrates the effect of share-based compensation on the statements of operations:
   Six months ended
June 30		   Three months ended
June 30		 
   2025   2024   2025   2024 
Cost of revenue  $
-
   $
-
   $
-
   $
    -
 
Research and development   251    410    128    278 
General, administrative and marketing   487    370    228    212 
   $738   $780   $356   $490